There is a statistic I share with all my young patients when we discuss preventive aging: collagen in our skin starts decreasing at 1% per year from age 25. It sounds small, but that 1% annual compound over 20 years means that at 45 you have 20% less collagen than at 25.
That silent mathematics is the reason preventive collagen biostimulation has solid logic.
In short: collagen biostimulators (Sculptra PLLA, Radiesse, and others) can play a preventive role when used at low doses at younger ages — not to add volume that has not yet been lost, but to “load” the collagen synthesis system and maintain its performance longer.
Collagen: what it is and why it matters so much
Collagen is the most abundant structural protein in the skin. It represents approximately 70% of the dry weight of the dermis. Its functions are multiple:
- Structural support: It is the “framework” that supports the other skin components
- Firmness and elasticity: Collagen fibers give skin resistance and allow it to return to its position
- Hydration: Collagen retains water in the dermis, contributing to visible skin hydration
Progressive collagen loss is one of the main mechanisms of skin aging. And that loss starts before it becomes visible.
What biostimulators actually are
Biostimulators are substances that, when injected into tissue, activate fibroblasts — the cells responsible for producing collagen — to increase their production.
Unlike fillers, they do not add volume mechanically. The result comes from your own collagen, produced by your own fibroblasts.
Main biostimulators available in Colombia:
Sculptra (poly-L-lactic acid, PLLA): The most studied with the greatest clinical evidence. PLLA microspheres act as scaffolding that stimulates fibroblasts. Result duration: 2–3 years. Approved since 1999 in Europe, since 2004 in the US.
Radiesse (calcium hydroxyapatite): Acts as a biostimulator and volume filler simultaneously. The hydroxyapatite microstructure stimulates collagen while providing an immediate volume effect. Duration: 12–18 months.
Belotero Revive (BDDE cross-linked HA + glycerin): More than a filler, formulated to improve dermal hydration and subtly stimulate collagen production. Primarily indicated for texture improvement.
Profhilo (ultra-high concentration HA): A bioremodeling product that intensely hydrates the dermis and indirectly stimulates collagen through its high hyaluronic acid concentration. Widely used in preventive medicine.
The preventive vs. corrective approach in biostimulators
This distinction is fundamental for understanding when biostimulation makes sense in a preventive context:
Corrective use (the classic indication)
45–55-year-old patient with visible volume loss, firmness loss, and skin quality deterioration. In this context, biostimulators are used at higher doses to recover lost collagen and restore tissue structure.
Preventive use (the emerging indication)
25–38-year-old patient with skin in good condition but with:
- Family history of early aging
- Chronic sun exposure
- Very subtle beginning of density or firmness loss
- Goal of maintaining skin in its current state longer
In this context, lower and more spaced doses are used, with the goal of “reminding” fibroblasts to stay active.
When I indicate preventive biostimulation at our clinic
Not every young patient needs biostimulators. My clinical criteria for recommending them in a preventive context:
Factors that move the indication forward:
- Intense chronic sun exposure without protection (accelerated photoaging)
- Active smoking (tobacco directly degrades collagen)
- Genetics of early aging (parents or grandparents with deep wrinkles from age 40)
- Significant recent weight loss that has affected skin firmness
- Very thin skin with early perceptible collagen loss on examination
When I wait:
- Patient under 28 without special risk factors with skin in excellent condition
- When priority should be basic skincare (sun protection, retinoids) before injectables
- When goals are unclear or unrealistic
The preventive biostimulation protocol I typically design
For a 30–35-year-old patient in a preventive context, a typical protocol might be:
Year 1:
- 2 Sculptra sessions at low doses (one vial per session, vs. 2–3 vials in corrective context), spaced 4–6 weeks apart
- Goal: diffuse collagen stimulation throughout the middle third and jawline
- Complemented with Profhilo or Belotero Revive for texture and hydration
Maintenance:
- 1 booster session annually to maintain active stimulation
- Evaluation every 6 months of skin evolution
This type of protocol, combined with active medical skincare and strict sun protection, can make a very visible difference in how skin looks at 45–50 years old.
Preventive biostimulation is not for everyone, and its indication must be individualized. If you want to know whether it makes sense in your case, I invite you to an evaluation consultation at our clinic.
Dr. Tatiana Leal is an aesthetic medicine specialist in Bogotá, Colombia.
Frequently asked questions
Collagen biostimulation can make preventive sense from ages 25–28 in patients with accelerated aging risk factors (chronic sun exposure, smoking, genetics of early aging). For most patients without risk factors, the preventive indication usually appears between ages 30 and 38, when collagen loss begins to become perceptible in skin texture and firmness.
In young patients, biostimulators are used at lower doses with a focus on general dermal stimulation, not correction of volume loss. The goal is to 'load' the collagen synthesis system so it maintains its pace longer. In older patients, biostimulators combine collagen stimulation with restoration of lost volume.
No. Fillers (like hyaluronic acid) add volume immediately and mechanically. Biostimulators (Sculptra PLLA, Radiesse, Belotero Revive) do not add immediate visible volume — they stimulate the body to produce its own collagen, gradually improving tissue quality and density. The result is more natural and longer-lasting.